Skip to content
OpenCapital
Get started

Baxter International BAX Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

Medline, Inc. logo
Medline, Inc. MDLN
-$13M-44.4%
Medtronic logo
MedtronicMDT
——
Solventum logo
SolventumSOLV
——
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——
Nordson logo
NordsonNDSN
——
Globus Medical logo
Globus MedicalGMED
——

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's cash provided by (used in) financing activity, including discontinued operation?
Baxter International (BAX) reported cash provided by (used in) financing activity, including discontinued operation of -$11M in Q1 2026.
How has Baxter International's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Baxter International's cash provided by (used in) financing activity, including discontinued operation increased by 99.7% year-over-year, from -$3.23B to -$11M.
What is the long-term trend for Baxter International's cash provided by (used in) financing activity, including discontinued operation?
Over 3 years (2021 to 2025), Baxter International's cash provided by (used in) financing activity, including discontinued operation has grown at a -20.0% compound annual growth rate (CAGR), from $8.25B to -$4.22B.
What does cash provided by (used in) financing activity, including discontinued operation mean?
Net cash movement related to borrowing, repaying debt, and paying shareholders.
How do you interpret cash provided by (used in) financing activity, including discontinued operation?
Negative net cash flow often indicates debt repayment or returning capital to shareholders, while positive flow suggests raising capital through debt or equity.
How does cash provided by (used in) financing activity, including discontinued operation compare across companies?
Standard section in the Statement of Cash Flows.